Cite
Characterization of a novel anti-PVRIG antibody with Fc-competent function that exerts strong antitumor effects via NK activation in preclinical models.
MLA
Xue, Hongyu, et al. “Characterization of a Novel Anti-PVRIG Antibody with Fc-Competent Function That Exerts Strong Antitumor Effects via NK Activation in Preclinical Models.” Cancer Immunology, Immunotherapy, vol. 73, no. 5, May 2024, pp. 1–13. EBSCOhost, https://doi.org/10.1007/s00262-024-03671-z.
APA
Xue, H., Zhang, Z., Li, L., Zhu, C., Fei, K., Sha, H., Wu, Z., Lin, X., Wang, F., Zhou, S., Deng, X., Li, Y., Chen, B., Xiong, Y., & Chen, K. (2024). Characterization of a novel anti-PVRIG antibody with Fc-competent function that exerts strong antitumor effects via NK activation in preclinical models. Cancer Immunology, Immunotherapy, 73(5), 1–13. https://doi.org/10.1007/s00262-024-03671-z
Chicago
Xue, Hongyu, Zhimin Zhang, Li Li, Chenjuan Zhu, Keke Fei, Huijun Sha, Zhihai Wu, et al. 2024. “Characterization of a Novel Anti-PVRIG Antibody with Fc-Competent Function That Exerts Strong Antitumor Effects via NK Activation in Preclinical Models.” Cancer Immunology, Immunotherapy 73 (5): 1–13. doi:10.1007/s00262-024-03671-z.